ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

BRIEF-Corrected-Admedus Unit Signs LOI To Fund Immunotherapy Business – Reuters

BRIEF-Corrected-Admedus Unit Signs LOI To Fund Immunotherapy BusinessReutersBRIEF-Corrected-Admedus Unit Signs LOI To Fund Immunotherapy Business. Reuters Staff. 1 Min Read. April 27 (Reuters) – Admedus Ltd: * UNIT SIGNS LETTER OF INTENT TO FUND … Continue reading

2018-04-27 Michael Zand NEWS

Children with SMA1 Show Remarkable Progress on Gene Therapy – MD Magazine

Continue reading

2018-04-27 Michael Zand NEWS

Children with SMA1 Show Remarkable Progress on Gene Therapy – MD Magazine


MD Magazine

Children with SMA1 Show Remarkable Progress on Gene Therapy
MD Magazine
Cecilia Pessoa Gingerich. @CeciliaKPG. Researchers testing AVXS-101 gene therapy for the treatment of children with spinal muscular atrophy type 1 reported remarkable progress on the Children’s Hospital of Philadelphia Infant Test of Neuromuscular …

Continue reading

2018-04-27 Michael Zand NEWS

STEMCELL Technologies announces $45 million government funding for advanced manufacturing facility – Voiceonline.com


MD Magazine

Children with SMA1 Show Remarkable Progress on Gene Therapy
MD Magazine
Cecilia Pessoa Gingerich. @CeciliaKPG. Researchers testing AVXS-101 gene therapy for the treatment of children with spinal muscular atrophy type 1 reported remarkable progress on the Children’s Hospital of Philadelphia Infant Test of Neuromuscular …

Continue reading

2018-04-27 Michael Zand NEWS

US senator presses for answers about Sunrise-based stem cell clinic – Sun Sentinel

Sun SentinelUS senator presses for answers about Sunrise-based stem cell clinicSun SentinelA U.S. senator is demanding answers about a Sunrise-based stem cell clinic accused of harming three women and about treatment listings on a government-run websit… Continue reading

2018-04-27 Michael Zand NEWS

Immunotherapy Offering New Approach To Treating Cancer – CBS Pittsburgh / KDKA

STEMCELL Technologies announces $45 million government funding for advanced manufacturing facility
Voiceonline.com
STEMCELL Technologies, Canada’s largest biotechnology company, on Wednesday announced a $45 million joint funding agreement between the Governments of Canada and British Columbia to help the company build a state-of-the-art advanced manufacturing …

and more »

Continue reading

2018-04-26 Michael Zand NEWS

FDA Approves First Gene Therapy Clinical Trial For Rare Disease – Hartford Courant

Hartford CourantFDA Approves First Gene Therapy Clinical Trial For Rare DiseaseHartford CourantThe ultimate goal for the gene therapy, according to David Weinstein, a key researcher and pediatric endocrinologist, is to prevent low blood sugars, elimina… Continue reading

2018-04-26 Michael Zand NEWS

Emerging Immunotherapy Options for Metastatic NSCLC – OncLive


CBS Pittsburgh / KDKA

Immunotherapy Offering New Approach To Treating Cancer
CBS Pittsburgh / KDKA
“I said, I saw it on television, what about this immunotherapy?” she asked her doctor. Her doctors said it wasn’t approved for her type of cancer, but then everything changed. “When I go to the hospital, he says, ‘I’m going to send your tumor in. The …

and more »

Continue reading

2018-04-26 Michael Zand NEWS
  • 1
  • …
  • 184
  • 185
  • 186
  • 187
  • 188
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

OncLive

Emerging Immunotherapy Options for Metastatic NSCLC
OncLive
I’m not sure we will reach really better data giving only immunotherapy checkpoint inhibitors. But then you have combination of checkpoints plus chemotherapy, and you have the combination of checkpoint and checkpoint, so CTLA-4 and anti-PD-1 or anti-PD …

and more »